Cargando…

LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans

BACKGROUND: Previous studies of lipoproteins in patients with sepsis have been performed on density fractions isolated by conventional ultracentrifugation that are heterogeneous and provide no information about the cargo of apoproteins present in the immunochemically distinct subclasses that populat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bagdade, John D., Jilma, Bernd, Hudgins, Lisa C., Alaupovic, Petar, McCurdy, Carrie E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972402/ https://www.ncbi.nlm.nih.gov/pubmed/29807532 http://dx.doi.org/10.1186/s12944-018-0769-6

Ejemplares similares

IMMUNOCHEMICAL STUDIES ON HUMAN PLASMA LIPOPROTEINS
por: Aladjem, Frederick, et al.
Publicado: (1957)

Single-Nucleotide Polymorphisms in LPA Explain Most of the Ancestry-Specific Variation in Lp(a) Levels in African Americans
por: Deo, Rahul C., et al.
Publicado: (2011)

Variation in LPA Is Associated with Lp(a) Levels in Three Populations from the Third National Health and Nutrition Examination Survey
por: Dumitrescu, Logan, et al.
Publicado: (2011)

A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction
por: Coassin, Stefan, et al.
Publicado: (2017)

LPA(1), LPA(2), LPA(4), and LPA(6) receptor expression during mouse brain development
por: Suckau, Olga, et al.
Publicado: (2019)

A genome-wide analysis of DNA methylation identifies a novel association signal for Lp(a) concentrations in the LPA promoter
por: Coassin, Stefan, et al.
Publicado: (2020)

Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification
por: Pechlivanis, Sonali, et al.
Publicado: (2020)

The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A
por: Grüneis, Rebecca, et al.
Publicado: (2022)

Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA(1), LPA(2), and LPA(3)
por: Alcántara-Hernández, Rocío, et al.
Publicado: (2015)

Elevated lipoprotein(a) and genetic polymorphisms in the LPA gene may predict cardiovascular events
por: Gu, Jun-Xu, et al.
Publicado: (2022)

Regulation of T Cell Motility In Vitro and In Vivo by LPA and LPA2
por: Knowlden, Sara A., et al.
Publicado: (2014)

Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene
por: Coassin, Stefan, et al.
Publicado: (2022)

Detection of Lipoprotein X (LpX): A challenge in patients with severe hypercholesterolaemia
por: Ćwiklińska, Agnieszka, et al.
Publicado: (2020)

Stress, Depression, Resilience and Ageing: A Role for the LPA-LPA(1) Pathway
por: Dario, Moreno-Fernández Román, et al.
Publicado: (2018)

Effects of the LPA(1) Receptor Deficiency and Stress on the Hippocampal LPA Species in Mice
por: Tabbai, Sara, et al.
Publicado: (2019)

An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model
por: Ma, Lin, et al.
Publicado: (2013)

Relationship Between Lipoprotein (a) [Lp(a)] and Cognition in Different Ischemic Stroke Subtypes
por: Li, Jingjing, et al.
Publicado: (2021)

LPA2 protein is involved in photosystem II assembly in Chlamydomonas reinhardtii
por: Cecchin, Michela, et al.
Publicado: (2021)

Dual PPAR α/γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia
por: Samuelsson, O., et al.
Publicado: (2013)

Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease
por: Trinder, Mark, et al.
Publicado: (2020)

Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease
por: Schachtl-Riess, Johanna F., et al.
Publicado: (2021)

LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study
por: Yu, Xuechen, et al.
Publicado: (2016)

Phosphatidic Acid Stimulates Myoblast Proliferation through Interaction with LPA1 and LPA2 Receptors
por: Gomez-Larrauri, Ana, et al.
Publicado: (2021)

Beef in an Optimal Lean Diet study: effects on lipids, lipoproteins, and apolipoproteins(1)(2)(3)
por: Roussell, Michael A, et al.
Publicado: (2012)

LPA Genotypes and Haplotypes Are Associated with Lipoprotein(a) Levels but Not Arterial Wall Properties in Stable Post-Coronary Event Patients with Very High Lipoprotein(a) Levels
por: Rehberger Likozar, Andreja, et al.
Publicado: (2021)

Adipose tissue insulin sensitivity and macrophage recruitment: Does PI3K pick the pathway?
por: McCurdy, Carrie E, et al.
Publicado: (2013)

LPA-induced suppression of periostin in human osteosarcoma cells is mediated by the LPA(1)/Egr-1 axis
por: Windischhofer, Werner, et al.
Publicado: (2012)

Immunochemical protocols
Publicado: (1998)

Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A(2 )(Lp-PLA(2 )): a review
por: Silva, Isis T, et al.
Publicado: (2011)

Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels
por: Schettler, Volker J. J., et al.
Publicado: (2015)

Lipoprotein(a) and vitamin C impair development of breast cancer tumors in Lp(a)+; Gulo(−/−) mice
por: Cha, John, et al.
Publicado: (2016)

LPA Scheme for the LHC Luminosity Upgrade
por: Bhat, C
Publicado: (2009)

Lysophosphatidic acid and its receptors LPA(1) and LPA(3) mediate paclitaxel-induced neuropathic pain in mice
por: Uchida, Hitoshi, et al.
Publicado: (2014)

Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
por: Passaro, Angelina, et al.
Publicado: (2018)

Oxidized phospholipids and lipoprotein-associated phospholipase A(2) as important determinants of Lp(a) functionality and pathophysiological role
por: Tselepis, Alexandros D.
Publicado: (2018)

Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a)
por: Schwarz, Andrea, et al.
Publicado: (2022)

LPA Is a Chemorepellent for B16 Melanoma Cells: Action through the cAMP-Elevating LPA(5) Receptor
por: Jongsma, Maikel, et al.
Publicado: (2011)

Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe?
por: Buchtele, Nina, et al.
Publicado: (2018)

STUDIES ON MENINGOCOCCAL INFECTION : XII. IMMUNOCHEMICAL STUDIES ON MENINGOCOCCUS TYPE II
por: Menzel, A. E. O., et al.
Publicado: (1942)

The PDZ Protein GIPC Regulates Trafficking of the LPA(1) Receptor from APPL Signaling Endosomes and Attenuates the Cell’s Response to LPA
por: Varsano, Tal, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n00c1lppunlgeljshgouefojds